The role of fetal viral infection in the development of adverse pregnancy outcomes

被引：0
|
作者：
Gibson, C
MacLennan, A
Goldwater, P
Haan, E
Priest, K
Dekker, G
机构：
[1] Univ Adelaide, Adelaide, SA, Australia
[2] Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA, Australia
[3] Dept Hlth, Epidemiol Branch, Adelaide, SA, Australia
来源：
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2005年 / 193卷 / 06期
关键词：
D O I：
10.1016/j.ajog.2005.10.760
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
667
引用
收藏
页码：S188 / S188
页数：1
相关论文
共 50 条
  • [41] Psychoneuroimmunology in pregnancy: Immune pathways linking stress with maternal health, adverse birth outcomes, and fetal development
    Christian, Lisa M.
    NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2012, 36 (01): : 350 - 361
  • [42] Viral Deregulation of Apoptotic Pathways and Its Correlation With Adverse Pregnancy Outcomes
    Tologkos, Stylianos
    Papadatou, Vasiliki
    Lampropoulou, Vasiliki
    Pagonopoulou, Olga
    Alexiadi, Christina Angelika
    Alexiadis, Triantafyllos
    Trypsianis, Gregory
    Meditskou, Soultana
    Lambropoulou, Maria
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [43] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Comment
    White, Tacey
    Williams, Amy
    DeSesso, John M.
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 124 - 125
  • [44] Risks of Selected Fetal Adverse Pregnancy Outcomes at Advance Maternal Age
    Yasmeen, Saadia
    Sumayya
    Saleem, Javeria
    Liaqat, Jawairiah
    Pervaiz, Nadia
    Rehman, Fatima
    PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES, 2021, 15 (08): : 2468 - 2471
  • [45] Ondansetron in pregnancy and risk of adverse fetal outcomes in the United States Response
    Sweeting, J. Nicole
    Wells, Peter G.
    REPRODUCTIVE TOXICOLOGY, 2016, 66 : 126 - 127
  • [46] Insulin glargine use in pregnancy is not associated with adverse maternal or fetal outcomes
    Gallen, Ian W.
    Jaap, Alan J.
    DIABETES, 2006, 55 : A417 - A417
  • [47] Chloroquine or hydroxychloroquine use during pregnancy not associated with adverse fetal outcomes
    Reactions Weekly, 2020, 1833 (1) : 3 - 3
  • [48] Fetal fraction in noninvasive prenatal testing and adverse pregnancy outcomes: a response
    Becking, Ellis C.
    Sistermans, Erik A.
    Bekker, Mireille N.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2024, 231 (01) : e56 - e56
  • [49] Are increased fetal movements during pregnancy a predictor of neonatal adverse outcomes?
    Cohen, Gal
    Bogin, Rona
    Schreiber, Hanoch
    Shechter-Maor, Gil
    Cohen, Ido
    Biron-Shental, Tal
    Daykan, Yair
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 227 (02) : 349 - 351
  • [50] Fetal isolated short femur in the second trimester and adverse pregnancy outcomes
    Ozlu, Tulay
    Ozcan, Tulin
    PRENATAL DIAGNOSIS, 2013, 33 (11) : 1063 - 1069
12345